Provided by Tiger Trade Technology Pte. Ltd.

AMPLIFY WEIGHT LOSS DRUG & TREATMENT ETF

27.91
+0.36001.31%
Post-market: 27.910.00000.00%16:10 EDT
Volume:1K
Turnover:30.31K
Market Cap:5.58M
PE:- -
High:27.94
Open:27.94
Low:27.88
Close:27.55
52wk High:27.94
52wk Low:22.63
Shares:200.00K
Float Shares:200.00K
Volume Ratio:0.20
T/O Rate:0.54%
Dividend:0.41
Dividend Rate:1.48%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Hims & Hers CFO Oluyemi Okupe Sells 64,771 Common Shares Worth $2.2 Million

Reuters
·
Aug 19

Eli Lilly & Co. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 19

Eli Lilly EVP, International President Patrik Jonsson Disposes of 6,500 Shares Worth $7.64 Million

Reuters
·
Aug 19

Eli Lilly and Co Stock (LLY) Moved Up by 3.19% on Aug 18: What Signal Does It Send?

TradingKey
·
Aug 19

Eli Lilly (LLY) Stock Looks Undervalued Relative To Fair Value

Simply Wall St.
·
Aug 19

Novo Nordisk Tests Semaglutide’s Alzheimer’s Potential: What Investors Should Watch

TIPRANKS
·
Aug 19

BMO Capital Remains a Hold on Novo Nordisk (NVO)

TIPRANKS
·
Aug 18

Hims & Hers Health (HIMS) Is Down 9.9% After FTC And Class Action Privacy Allegations - What's Changed

Simply Wall St.
·
Aug 18

Eli Lilly Pays $10 Million Upfront to AlzeCure Under Alzstatin Deal

MT Newswires Live
·
Aug 18

Novo Nordisk Lawsuit Ruling Lets Some Securities Claims Move Forward

TIPRANKS
·
Aug 18

Sector Update: Healthcare

MT Newswires Live
·
Aug 18

Top Midday Gainers

MT Newswires Live
·
Aug 18

Novo Nordisk A/S Series B Stock Falls Monday, Underperforms Market

Dow Jones
·
Aug 18

Eli Lilly Canada: Disagrees with Characterizations in Canada Revenue Agency’s Application; Will Respond Formally Through Court Process in Due Course

THOMSON REUTERS
·
Aug 17

Eli Lilly Canada: Continues to Take Action to Address Promotion and Sale of Unapproved and Illegal Retatrutide Products in Canada

THOMSON REUTERS
·
Aug 17

PRESS Digest-Canada - August 17

Reuters
·
Aug 17

Leal Therapeutics: Raises $30M in Series a Extension Financing, Adds Eli Lilly as New Investor

THOMSON REUTERS
·
Aug 17

Eli Lily Initiates New Phase Iii Clinical Trials for Adult Depression Treatment Brenipatide in China - Notice

THOMSON REUTERS
·
Aug 17

Eli Lily Initiates New Phase III Clinical Trials for Brenipatide in China

Reuters
·
Aug 17

The Mediterranean Diet is the Best One Out There. Here's Why Americans Struggle with It.

Dow Jones
·
Aug 17